ACETAMINOPHEN, ASPIRIN AND CAFFEINE

ACETAMINOPHEN, ASPIRIN AND CAFFEINE was reported 21130 times

ACETAMINOPHEN, ASPIRIN AND CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POST GASTRIC SURGERY SYNDROME 1 0.0111
1 BLEEDING TIME ABNORMAL 1 0.0097
2 MANUFACTURING PRODUCTION ISSUE 1 0.0096
3 GALLOP RHYTHM PRESENT 1 0.0084
4 PILONIDAL DISEASE 1 0.0042
5 ANORECTAL INFECTION 1 0.0040
6 ANTICOAGULANT THERAPY 1 0.0035
7 MEDICATION OVERUSE HEADACHE 3 0.0035
8 WHITE BLOOD CELL COUNT 1 0.0034
9 VISUAL ACUITY REDUCED TRANSIENTLY 1 0.0032
10 HEPATIC VEIN THROMBOSIS 1 0.0032
11 PERIPHERAL NERVE LESION 1 0.0030
12 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
13 NSAID EXACERBATED RESPIRATORY DISEASE 1 0.0026
14 ACCELERATED HYPERTENSION 1 0.0026
15 HOUSEBOUND 1 0.0025
16 OESOPHAGEAL DILATATION 1 0.0023
17 INFUSION SITE SCAR 1 0.0023
18 OESOPHAGEAL INFECTION 1 0.0022
19 HYPERVIGILANCE 2 0.0021
20 ORAL LICHEN PLANUS 1 0.0020
21 POSTNASAL DRIP 1 0.0018
22 BLOOD BILIRUBIN DECREASED 1 0.0016
23 INTESTINAL FUNCTIONAL DISORDER 1 0.0016
24 INTENTIONAL MISUSE 3 0.0016
25 SPUTUM PURULENT 1 0.0015
26 DELIVERY 1 0.0015
27 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
28 ARTHROSCOPY 1 0.0015
29 MULTIPLE DRUG THERAPY 1 0.0013
30 ARTERIAL RUPTURE 1 0.0013
31 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
32 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
33 EROSIVE OESOPHAGITIS 2 0.0012
34 SEDATION COMPLICATION 3 0.0012
35 MALIGNANT HYPERTENSION 1 0.0012
36 HEART TRANSPLANT 1 0.0011
37 BONE CONTUSION 1 0.0011
38 PRODUCT APPEARANCE CONFUSION 1 0.0011
39 PROSTATE INFECTION 1 0.0010
40 RED BLOOD CELLS URINE POSITIVE 1 0.0010
41 HYPOGEUSIA 2 0.0010
42 OROPHARYNGEAL SWELLING 1 0.0010
43 NASAL INFLAMMATION 1 0.0009
44 PRODUCT COMMINGLING 1 0.0009
45 GASTROINTESTINAL ULCER 2 0.0009
46 URINARY TRACT DISORDER 4 0.0009
47 BLOODY DISCHARGE 1 0.0009
48 LIBIDO DISORDER 1 0.0008
49 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
50 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
51 TONGUE DRY 1 0.0007
52 EFFUSION 1 0.0007
53 SUDDEN ONSET OF SLEEP 1 0.0007
54 APPENDIX DISORDER 1 0.0007
55 GENITAL RASH 1 0.0007
56 GASTRITIS HAEMORRHAGIC 1 0.0007
57 HYPOAESTHESIA FACIAL 1 0.0007
58 HYPOSMIA 1 0.0007
59 BLOOD PRESSURE IMMEASURABLE 1 0.0007
60 VASCULAR RUPTURE 1 0.0006
61 INTRA-UTERINE DEATH 1 0.0006
62 COSTOCHONDRITIS 1 0.0006
63 LAZINESS 1 0.0006
64 BLOOD PH DECREASED 1 0.0006
65 BLOOD AMYLASE INCREASED 1 0.0006
66 SPONDYLOLISTHESIS 1 0.0006
67 INFUSION SITE DISCHARGE 1 0.0006
68 SKIN HYPOPIGMENTATION 1 0.0006
69 MITRAL VALVE DISEASE 1 0.0006
70 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
71 HYPERTRICHOSIS 1 0.0005
72 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
73 BLOOD BICARBONATE DECREASED 1 0.0005
74 PANCREATIC CYST 1 0.0005
75 PRODUCT ODOUR ABNORMAL 5 0.0005
76 DILATATION VENTRICULAR 1 0.0005
77 INTERVERTEBRAL DISC DISORDER 2 0.0005
78 RHEUMATIC FEVER 2 0.0004
79 INFECTIOUS MONONUCLEOSIS 1 0.0004
80 KOUNIS SYNDROME 1 0.0004
81 RENAL FUNCTION TEST ABNORMAL 2 0.0004
82 INFUSION SITE INFECTION 1 0.0004
83 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
84 GASTRITIS EROSIVE 2 0.0004
85 SINUS PAIN 1 0.0004
86 PATELLA FRACTURE 1 0.0004
87 PRURITUS GENITAL 1 0.0004
88 SPINAL DISORDER 4 0.0004
89 PUSTULE 1 0.0004
90 ORAL INTAKE REDUCED 1 0.0004
91 SLOW SPEECH 1 0.0004
92 PRODUCT PACKAGING CONFUSION 1 0.0004
93 DEVICE INFUSION ISSUE 1 0.0004
94 MULTIPLE DRUG OVERDOSE 2 0.0004
95 VENTRICULAR HYPERTROPHY 1 0.0004
96 VASODILATATION 1 0.0004
97 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
98 HAEMORRHAGE URINARY TRACT 1 0.0004
99 MENOPAUSE 1 0.0004
100 HERNIA REPAIR 1 0.0004
101 RETINAL DISORDER 1 0.0004
102 EAR CONGESTION 1 0.0004
103 DRUG TOXICITY 5 0.0004
104 JOINT LOCK 1 0.0004
105 DUODENAL ULCER HAEMORRHAGE 1 0.0003
106 EYELID MARGIN CRUSTING 1 0.0003
107 VOMITING PROJECTILE 1 0.0003
108 LUMBAR SPINAL STENOSIS 1 0.0003
109 BLEPHAROSPASM 2 0.0003
110 NON-CARDIAC CHEST PAIN 1 0.0003
111 FAECAL CALPROTECTIN INCREASED 1 0.0003
112 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
113 INFUSION SITE HAEMORRHAGE 1 0.0003
114 THERAPEUTIC AGENT TOXICITY 1 0.0003
115 PRODUCT LABEL ISSUE 2 0.0003
116 VIITH NERVE PARALYSIS 1 0.0003
117 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
118 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
119 LUNG TRANSPLANT 1 0.0003
120 MACULOPATHY 1 0.0003
121 SKIN WEEPING 1 0.0003
122 SPONDYLITIS 1 0.0003
123 DEVICE KINK 1 0.0003
124 RECTAL DISCHARGE 1 0.0003
125 BLOOD CALCIUM DECREASED 3 0.0003
126 COMMUNICATION DISORDER 1 0.0003
127 GASTRIC HAEMORRHAGE 3 0.0003
128 OESOPHAGEAL ULCER 1 0.0003
129 FAECES HARD 1 0.0003
130 IMMOBILE 1 0.0002
131 GRIP STRENGTH DECREASED 2 0.0002
132 IRON DEFICIENCY 1 0.0002
133 PRODUCT TASTE ABNORMAL 3 0.0002
134 SUSPECTED OFF LABEL USE 1 0.0002
135 EXOSTOSIS 2 0.0002
136 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
137 BLOOD PROLACTIN INCREASED 1 0.0002
138 GASTRIC ULCER 4 0.0002
139 GESTATIONAL DIABETES 1 0.0002
140 LIMB OPERATION 1 0.0002
141 EXPIRED DRUG ADMINISTERED 1 0.0002
142 BLADDER DISORDER 2 0.0002
143 HEPATIC ENZYME ABNORMAL 1 0.0002
144 HYPERAMMONAEMIA 1 0.0002
145 CORONARY ARTERY STENOSIS 1 0.0002
146 PATHOLOGICAL FRACTURE 1 0.0002
147 PRODUCT COLOUR ISSUE 1 0.0002
148 FAILURE TO THRIVE 1 0.0002
149 BLOOD LACTIC ACID INCREASED 1 0.0002
150 ANORECTAL DISCOMFORT 1 0.0002
151 ANAL FISSURE 1 0.0002
152 ERYTHEMA OF EYELID 1 0.0002
153 NORMAL NEWBORN 1 0.0002
154 ASTHENOPIA 1 0.0002
155 STREPTOCOCCAL INFECTION 1 0.0002
156 HEART RATE ABNORMAL 1 0.0002
157 REBOUND EFFECT 2 0.0002
158 PERIORBITAL SWELLING 1 0.0002
159 PERONEAL NERVE PALSY 1 0.0002
160 SCAR 3 0.0002
161 MADAROSIS 2 0.0002
162 ORTHOSTATIC HYPOTENSION 3 0.0002
163 RALES 1 0.0002
164 SKIN WARM 1 0.0002
165 PRODUCT LABEL CONFUSION 1 0.0002
166 URINE ODOUR ABNORMAL 1 0.0002
167 ENERGY INCREASED 1 0.0002
168 SINUS HEADACHE 1 0.0002
169 PLATELET COUNT ABNORMAL 1 0.0002
170 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
171 SCOLIOSIS 1 0.0002
172 INFUSION SITE EXTRAVASATION 1 0.0002
173 PHOTOPHOBIA 3 0.0002
174 INFUSION SITE SWELLING 1 0.0002
175 PHOTOPSIA 1 0.0002
176 HIATUS HERNIA 2 0.0002
177 SEDATION 4 0.0002
178 POLYP 1 0.0002
179 SOMNAMBULISM 1 0.0002
180 PRODUCT FORMULATION ISSUE 1 0.0002
181 SINUS DISORDER 3 0.0002
182 BREAST MASS 1 0.0001
183 BRONCHIECTASIS 1 0.0001
184 INFARCTION 1 0.0001
185 EYE MOVEMENT DISORDER 1 0.0001
186 NEPHROTIC SYNDROME 1 0.0001
187 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
188 EXTRASYSTOLES 1 0.0001
189 DEFAECATION URGENCY 1 0.0001
190 RIGHT VENTRICULAR FAILURE 1 0.0001
191 METASTASIS 1 0.0001
192 INJECTION SITE HAEMATOMA 2 0.0001
193 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
194 BLINDNESS TRANSIENT 1 0.0001
195 FEELING DRUNK 1 0.0001
196 GENERAL SYMPTOM 1 0.0001
197 PAROSMIA 1 0.0001
198 ACIDOSIS 1 0.0001
199 BOWEL MOVEMENT IRREGULARITY 1 0.0001
200 LIPASE INCREASED 1 0.0001
201 RENAL FAILURE CHRONIC 1 0.0001
202 ATRIOVENTRICULAR BLOCK 1 0.0001
203 CONCUSSION 1 0.0001
204 APHTHOUS ULCER 1 0.0001
205 HYPOALBUMINAEMIA 1 0.0001
206 PRODUCT USE COMPLAINT 2 0.0001
207 BLOOD ALBUMIN DECREASED 1 0.0001
208 MOBILITY DECREASED 9 0.0001
209 MIOSIS 1 0.0001
210 ABNORMAL FAECES 1 0.0001
211 VENTRICULAR TACHYCARDIA 2 0.0001
212 VIRAL INFECTION 4 0.0001
213 COMPLETED SUICIDE 10 0.0001
214 INFUSION SITE ERYTHEMA 1 0.0001
215 FACE OEDEMA 2 0.0001
216 SKIN PLAQUE 1 0.0001
217 PSEUDOMONAS INFECTION 1 0.0001
218 CARDIAC MURMUR 1 0.0001
219 PYELONEPHRITIS 1 0.0001
220 SKIN SWELLING 1 0.0001
221 GASTRITIS 3 0.0001
222 WRONG DRUG ADMINISTERED 1 0.0001
223 GASTROENTERITIS VIRAL 2 0.0001
224 ERYTHEMA MULTIFORME 1 0.0001
225 SPUTUM DISCOLOURED 1 0.0001
226 BLOOD URINE PRESENT 2 0.0001
227 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
228 ACUTE RESPIRATORY FAILURE 2 0.0001
229 SINUS BRADYCARDIA 1 0.0001
230 DIZZINESS POSTURAL 1 0.0001
231 HAEMORRHOIDS 2 0.0001
232 HEPATOMEGALY 1 0.0001
233 HOSPICE CARE 1 0.0001
234 EMPHYSEMA 1 0.0001
235 DRY THROAT 1 0.0001
236 DRUG ADMINISTRATION ERROR 3 0.0001
237 EUPHORIC MOOD 1 0.0001
238 RIB FRACTURE 2 0.0001
239 EYE DISCHARGE 1 0.0001
240 JOINT DISLOCATION 1 0.0001
241 SUDDEN DEATH 1 0.0001
242 CYSTITIS 3 0.0001
243 INTENTIONAL OVERDOSE 6 0.0001
244 BODY HEIGHT DECREASED 1 0.0001
245 MOVEMENT DISORDER 3 0.0001
246 POOR QUALITY SLEEP 2 0.0001
247 PHARYNGITIS STREPTOCOCCAL 1 0.0001
248 FAECES DISCOLOURED 2 0.0001
249 OESOPHAGITIS 1 0.0001
250 STEVENS-JOHNSON SYNDROME 2 0.0001
251 NEPHROPATHY TOXIC 1 0.0001
252 OCULAR DISCOMFORT 1 0.0001
253 IMPAIRED DRIVING ABILITY 1 0.0001
254 GASTRIC DISORDER 3 0.0001
255 NEOPLASM 1 0.0001
256 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
257 EYELID OEDEMA 1 0.0001
258 COGNITIVE DISORDER 4 0.0001
259 SPINAL PAIN 1 0.0001
260 BLOOD IRON DECREASED 1 0.0001
261 MIGRAINE 8 0.0001
262 ACCIDENT 1 0.0001
263 MUSCLE SPASTICITY 1 0.0001
264 CARDIOMEGALY 1 0.0001
265 SPINAL OPERATION 1 0.0001
266 SECRETION DISCHARGE 1 0.0001
267 INFUSION SITE PAIN 1 0.0001
268 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
269 ORAL CANDIDIASIS 1 0.0001
270 TOOTH INFECTION 1 0.0001
271 PULMONARY CONGESTION 1 0.0001
272 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
273 QUALITY OF LIFE DECREASED 1 0.0001
274 UVEITIS 1 0.0001
275 TACHYPNOEA 1 0.0001
276 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
277 RESPIRATORY ARREST 2 0.0001
278 DRUG ABUSE 6 0.0001
279 MENTAL STATUS CHANGES 2 0.0001
280 MASS 1 0.0001
281 BLOOD TEST ABNORMAL 1 0.0001
282 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
283 BLINDNESS UNILATERAL 1 0.0001
284 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
285 DIALYSIS 1 0.0001
286 INTENTIONAL DOSE OMISSION 2 0.0001
287 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
288 PARALYSIS 1 0.0001
289 BALANCE DISORDER 6 0.0001
290 PARAESTHESIA ORAL 1 0.0001
291 ANOSMIA 1 0.0001
292 HYPOKINESIA 1 0.0001
293 UNDERDOSE 5 0.0001
294 CARDIOMYOPATHY 1 0.0001
295 SKIN HAEMORRHAGE 1 0.0001
296 BLOOD POTASSIUM DECREASED 2 0.0001
297 HEPATIC FAILURE 2 0.0001
298 HYPOAESTHESIA ORAL 1 0.0001
299 ECONOMIC PROBLEM 1 0.0001
300 STOMATITIS 4 0.0001
301 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
302 SKIN IRRITATION 3 0.0001
303 INSURANCE ISSUE 1 0.0001
304 PHARYNGEAL OEDEMA 1 0.0001
305 FEMUR FRACTURE 2 0.0001
306 EJECTION FRACTION DECREASED 1 0.0001
307 CONSTIPATION 14 0.0001
308 THERAPY PARTIAL RESPONDER 1 0.0001
309 HEAD INJURY 2 0.0001
310 RESPIRATORY TRACT CONGESTION 1 0.0001
311 BLOOD GLUCOSE DECREASED 3 0.0001
312 SENSORY DISTURBANCE 1 0.0001
313 CHOLELITHIASIS 2 0.0001
314 MANIA 1 0.0001
315 DRUG LEVEL INCREASED 1 0.0001
316 VISUAL ACUITY REDUCED 2 0.0001
317 DRY EYE 3 0.0001
318 COAGULOPATHY 1 0.0001
319 CELLULITIS 3 0.0001
320 PRODUCT QUALITY ISSUE 8 0.0001
321 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
322 PARANOIA 1 0.0001
323 MULTI-ORGAN FAILURE 1 0.0001
324 DEVICE DEFECTIVE 1 0.0001
325 INTENTIONAL PRODUCT MISUSE 5 0.0001
326 MUSCULOSKELETAL STIFFNESS 5 0.0001
327 METASTASES TO LIVER 1 0.0001
328 COLD SWEAT 1 0.0001
329 GALLBLADDER DISORDER 1 0.0001
330 PRODUCT ADHESION ISSUE 2 0.0001
331 OSTEOMYELITIS 1 0.0001
332 RESTLESS LEGS SYNDROME 1 0.0001
333 TREATMENT NONCOMPLIANCE 3 0.0001
334 ACCIDENTAL OVERDOSE 2 0.0001
335 AGITATION 4 0.0001
336 BRONCHITIS 4 0.0001
337 MEDICATION ERROR 3 0.0001
338 CONJUNCTIVITIS 1 0.0001
339 BACTERIAL INFECTION 1 0.0001
340 HEPATIC FUNCTION ABNORMAL 2 0.0001
341 MIDDLE INSOMNIA 1 0.0001
342 INTESTINAL OBSTRUCTION 2 0.0001
343 BLOOD SODIUM DECREASED 1 0.0001
344 FLATULENCE 3 0.0001
345 HYPOCALCAEMIA 1 0.0001
346 FOOT FRACTURE 1 0.0001
347 PROTEINURIA 1 0.0001
348 MUSCULOSKELETAL DISORDER 1 0.0001
349 GLAUCOMA 1 0.0001
350 HERNIA 1 0.0001
351 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
352 PALPITATIONS 6 0.0001
353 ORAL HERPES 1 0.0001
354 SURGERY 3 0.0001
355 SKIN FISSURES 1 0.0001
356 KIDNEY INFECTION 1 0.0001
357 HAEMATOCRIT DECREASED 1 0.0001
358 BLOOD PRESSURE ABNORMAL 1 0.0001
359 SOMNOLENCE 10 0.0000
360 EXTRA DOSE ADMINISTERED 2 0.0000
361 FEEDING DISORDER 1 0.0000
362 TASTE DISORDER 1 0.0000
363 FLUSHING 5 0.0000
364 BODY TEMPERATURE INCREASED 1 0.0000
365 RHABDOMYOLYSIS 2 0.0000
366 POLLAKIURIA 2 0.0000
367 CARDIO-RESPIRATORY ARREST 2 0.0000
368 DERMATITIS 1 0.0000
369 KNEE ARTHROPLASTY 1 0.0000
370 TOXICITY TO VARIOUS AGENTS 8 0.0000
371 SKIN EXFOLIATION 4 0.0000
372 OSTEOARTHRITIS 2 0.0000
373 EATING DISORDER 1 0.0000
374 URINARY TRACT INFECTION 8 0.0000
375 IMPAIRED WORK ABILITY 1 0.0000
376 IRRITABLE BOWEL SYNDROME 1 0.0000
377 RECTAL HAEMORRHAGE 2 0.0000
378 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
379 TOOTH DISORDER 1 0.0000
380 PULMONARY OEDEMA 2 0.0000
381 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
382 PANCREATITIS ACUTE 1 0.0000
383 CHROMATURIA 1 0.0000
384 HEART RATE IRREGULAR 1 0.0000
385 PRODUCT AVAILABILITY ISSUE 1 0.0000
386 ABDOMINAL PAIN UPPER 9 0.0000
387 TINNITUS 2 0.0000
388 SHOCK 1 0.0000
389 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
390 HYPERTENSION 9 0.0000
391 PRODUCTIVE COUGH 2 0.0000
392 FEELING ABNORMAL 10 0.0000
393 BLOOD PRESSURE FLUCTUATION 1 0.0000
394 LOCALISED INFECTION 1 0.0000
395 NEURALGIA 1 0.0000
396 CEREBRAL INFARCTION 1 0.0000
397 ENCEPHALOPATHY 1 0.0000
398 ABASIA 1 0.0000
399 AGEUSIA 1 0.0000
400 COVID-19 7 0.0000
401 HYPOTENSION 8 0.0000
402 ABDOMINAL PAIN LOWER 1 0.0000
403 PRODUCT COMPLAINT 1 0.0000
404 WEIGHT DECREASED 11 0.0000
405 CARDIOVASCULAR DISORDER 1 0.0000
406 HYPOPHAGIA 1 0.0000
407 CHEST DISCOMFORT 4 0.0000
408 SINUSITIS 4 0.0000
409 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
410 INFLAMMATION 2 0.0000
411 BACK PAIN 9 0.0000
412 SKIN ULCER 1 0.0000
413 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
414 RESPIRATORY TRACT INFECTION 1 0.0000
415 NERVOUSNESS 2 0.0000
416 ECZEMA 2 0.0000
417 DRUG INTERACTION 6 0.0000
418 CHEST PAIN 7 0.0000
419 BRADYCARDIA 2 0.0000
420 EAR INFECTION 1 0.0000
421 MENSTRUATION IRREGULAR 1 0.0000
422 FEAR 1 0.0000
423 JAUNDICE 1 0.0000
424 PAIN OF SKIN 1 0.0000
425 DISTURBANCE IN ATTENTION 2 0.0000
426 ANAEMIA 7 0.0000
427 MOOD ALTERED 1 0.0000
428 PRURITUS 14 0.0000
429 HAEMATOCHEZIA 2 0.0000
430 RESPIRATORY DISTRESS 1 0.0000
431 ANAPHYLACTIC REACTION 2 0.0000
432 FEELING COLD 1 0.0000
433 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
434 INFLUENZA 4 0.0000
435 HAEMOPTYSIS 1 0.0000
436 DEMENTIA 1 0.0000
437 EYE PAIN 2 0.0000
438 RED BLOOD CELL COUNT DECREASED 1 0.0000
439 ANGINA PECTORIS 1 0.0000
440 HYPERSOMNIA 1 0.0000
441 PRODUCT SUBSTITUTION ISSUE 2 0.0000
442 NAUSEA 27 0.0000
443 NASAL CONGESTION 2 0.0000
444 ASCITES 1 0.0000
445 PRODUCT DOSE OMISSION ISSUE 10 0.0000
446 URINARY INCONTINENCE 1 0.0000
447 CATARACT 2 0.0000
448 RESPIRATORY DISORDER 1 0.0000
449 APHASIA 1 0.0000
450 LACRIMATION INCREASED 1 0.0000
451 CORONARY ARTERY DISEASE 1 0.0000
452 THERAPEUTIC RESPONSE DECREASED 2 0.0000
453 CONDITION AGGRAVATED 10 0.0000
454 VERTIGO 2 0.0000
455 DISCOMFORT 2 0.0000
456 EPILEPSY 1 0.0000
457 NASOPHARYNGITIS 6 0.0000
458 OVERDOSE 7 0.0000
459 EMOTIONAL DISORDER 1 0.0000
460 GYNAECOMASTIA 1 0.0000
461 COUGH 9 0.0000
462 NERVOUS SYSTEM DISORDER 1 0.0000
463 SWOLLEN TONGUE 1 0.0000
464 HEADACHE 20 0.0000
465 DRUG-INDUCED LIVER INJURY 1 0.0000
466 PARAESTHESIA 5 0.0000
467 NEUROPATHY PERIPHERAL 3 0.0000
468 METABOLIC ACIDOSIS 1 0.0000
469 HIP FRACTURE 1 0.0000
470 PNEUMONIA 10 0.0000
471 SWELLING FACE 2 0.0000
472 DYSPEPSIA 3 0.0000
473 IMPAIRED HEALING 1 0.0000
474 EYE DISORDER 1 0.0000
475 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
476 BLOOD PRESSURE DECREASED 2 0.0000
477 LIP SWELLING 1 0.0000
478 URINARY RETENTION 1 0.0000
479 DRY SKIN 4 0.0000
480 ABDOMINAL DISCOMFORT 5 0.0000
481 MYALGIA 5 0.0000
482 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
483 ASTHENIA 11 0.0000
484 HAEMATURIA 1 0.0000
485 VISION BLURRED 4 0.0000
486 NIGHTMARE 1 0.0000
487 HAEMORRHAGE 3 0.0000
488 SLEEP DISORDER 2 0.0000
489 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
490 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
491 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
492 INFECTION 4 0.0000
493 DRUG EFFECT INCOMPLETE 1 0.0000
494 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
495 DYSURIA 1 0.0000
496 FALL 9 0.0000
497 HYPERSENSITIVITY 5 0.0000
498 DYSGEUSIA 2 0.0000
499 DYSARTHRIA 1 0.0000
500 DYSPNOEA EXERTIONAL 1 0.0000
501 HOT FLUSH 2 0.0000
502 MUSCULAR WEAKNESS 3 0.0000
503 DIARRHOEA 17 0.0000
504 GAIT DISTURBANCE 5 0.0000
505 ABDOMINAL PAIN 6 0.0000
506 PLASMA CELL MYELOMA 1 0.0000
507 DISORIENTATION 1 0.0000
508 OFF LABEL USE 22 0.0000
509 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
510 DRY MOUTH 2 0.0000
511 BLINDNESS 1 0.0000
512 FATIGUE 19 0.0000
513 OSTEOPOROSIS 1 0.0000
514 CARDIAC ARREST 2 0.0000
515 DIZZINESS 12 0.0000
516 RENAL IMPAIRMENT 2 0.0000
517 VOMITING 11 0.0000
518 HYPERHIDROSIS 3 0.0000
519 HYPOACUSIS 1 0.0000
520 MENTAL DISORDER 1 0.0000
521 DYSPNOEA 13 0.0000
522 MYOCARDIAL INFARCTION 4 0.0000
523 MALAISE 10 0.0000
524 PAIN 14 0.0000
525 ANGIOEDEMA 1 0.0000
526 RENAL FAILURE 3 0.0000
527 LIVER DISORDER 1 0.0000
528 TACHYCARDIA 2 0.0000
529 DEHYDRATION 3 0.0000
530 GASTROINTESTINAL DISORDER 2 0.0000
531 THROAT IRRITATION 1 0.0000
532 THERAPY NON-RESPONDER 1 0.0000
533 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
534 MEMORY IMPAIRMENT 3 0.0000
535 SKIN DISCOLOURATION 1 0.0000
536 ADVERSE EVENT 2 0.0000
537 HYPOKALAEMIA 1 0.0000
538 ARTHRALGIA 9 0.0000
539 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
540 OROPHARYNGEAL PAIN 2 0.0000
541 RENAL DISORDER 1 0.0000
542 ARRHYTHMIA 1 0.0000
543 DISEASE RECURRENCE 1 0.0000
544 RENAL CANCER 1 0.0000
545 MULTIPLE SCLEROSIS 1 0.0000
546 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
547 ATRIAL FIBRILLATION 2 0.0000
548 LUNG DISORDER 1 0.0000
549 PAIN IN EXTREMITY 6 0.0000
550 SYNCOPE 2 0.0000
551 AGGRESSION 1 0.0000
552 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
553 DRUG INEFFECTIVE 26 0.0000
554 FLUID RETENTION 1 0.0000
555 THERAPY CESSATION 1 0.0000
556 HAEMOGLOBIN DECREASED 2 0.0000
557 ERYTHEMA 4 0.0000
558 ILLNESS 2 0.0000
559 ABDOMINAL DISTENSION 2 0.0000
560 MUSCULOSKELETAL PAIN 1 0.0000
561 SPEECH DISORDER 1 0.0000
562 PANCREATITIS 1 0.0000
563 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
564 DRUG EFFECT DECREASED 1 0.0000
565 RASH PRURITIC 1 0.0000
566 OEDEMA 1 0.0000
567 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
568 SEPSIS 2 0.0000
569 URTICARIA 3 0.0000
570 BLISTER 1 0.0000
571 CEREBROVASCULAR ACCIDENT 3 0.0000
572 DEPRESSION 4 0.0000
573 CONVULSION 1 0.0000
574 HERPES ZOSTER 1 0.0000
575 LETHARGY 1 0.0000
576 EYE IRRITATION 1 0.0000
577 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
578 DECREASED APPETITE 4 0.0000
579 BONE PAIN 1 0.0000
580 BLADDER CANCER 1 0.0000
581 IRRITABILITY 1 0.0000
582 SUICIDE ATTEMPT 1 0.0000
583 OEDEMA PERIPHERAL 2 0.0000
584 FEELING HOT 1 0.0000
585 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
586 RHINORRHOEA 1 0.0000
587 AMNESIA 1 0.0000
588 PRODUCT DOSE OMISSION 1 0.0000
589 ALOPECIA 3 0.0000
590 INSOMNIA 4 0.0000
591 INJECTION SITE REACTION 1 0.0000
592 PYREXIA 5 0.0000
593 DEVICE MALFUNCTION 1 0.0000
594 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
595 ANXIETY 4 0.0000
596 THERAPY INTERRUPTED 1 0.0000
597 SKIN BURNING SENSATION 1 0.0000
598 RASH 6 0.0000
599 RESPIRATORY FAILURE 1 0.0000
600 WEIGHT INCREASED 3 0.0000
601 EPISTAXIS 1 0.0000
602 HYPOAESTHESIA 2 0.0000
603 HALLUCINATION 1 0.0000
604 ACNE 1 0.0000
605 DIABETES MELLITUS 1 0.0000
606 BLOOD PRESSURE INCREASED 2 0.0000
607 ARTHRITIS 1 0.0000
608 INJECTION SITE BRUISING 1 0.0000
609 INJECTION SITE HAEMORRHAGE 1 0.0000
610 CARDIAC FAILURE 1 0.0000
611 CARDIAC FAILURE CONGESTIVE 1 0.0000
612 DRUG DEPENDENCE 2 0.0000
613 PROSTATE CANCER 1 0.0000
614 THROMBOSIS 1 0.0000
615 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
616 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
617 DEVICE ISSUE 1 0.0000
618 MUSCLE SPASMS 2 0.0000
619 BLOOD GLUCOSE INCREASED 2 0.0000
620 CONTUSION 1 0.0000
621 HEART RATE INCREASED 1 0.0000
622 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
623 PLATELET COUNT DECREASED 1 0.0000
624 THROMBOCYTOPENIA 1 0.0000
625 SEIZURE 1 0.0000
626 CHILLS 1 0.0000
627 DISEASE PROGRESSION 1 0.0000
628 JOINT SWELLING 1 0.0000
629 VISUAL IMPAIRMENT 1 0.0000
630 LOSS OF CONSCIOUSNESS 1 0.0000
631 PSORIASIS 1 0.0000
632 DEATH 6 0.0000
633 HOSPITALISATION 1 0.0000
634 PERIPHERAL SWELLING 1 0.0000
635 CONFUSIONAL STATE 1 0.0000
636 DRUG DOSE OMISSION 1 0.0000
637 TREMOR 1 0.0000
638 NO ADVERSE EVENT 1 0.0000
639 PRODUCT USE ISSUE 1 0.0000